Library > Country Reports > Europe



Having largely recovered from the impact of the global financial crisis and with several impressive fundamentals in place, Spain once again stands as one of Europe’s premier healthcare and life science investment destinations. These fundamentals include a revamped market…

A light regulatory touch has long attracted companies to establish R&D and manufacturing plants for generic pharmaceuticals in Malta in the knowledge that products developed on the island can be launched globally immediately on the expiry of the originator drug – a…

With GDP growth at 4.6% for 2017, pharma market growth of 4.2%, 38 million people, and a strategic location in the center of Europe, Poland has solid foundations for success in healthcare and the life sciences. The situation is improving for both generics companies and…

Despite a tiny domestic market size, the Lithuanian life sciences sector is full of hidden surprises. Comprising four percent of the nation’s entire GDP, with one percent accounted for by a burgeoning biotechnology sector, Lithuania can draw on a strong science R&D…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country  located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…

With an admirable legacy of excellence behind it, Austria’s healthcare and life science industry is poised to take the next step and help make the country a genuine hub for both its region and for Europe. Vienna is already fast establishing itself as Central…

Squirreled away right on the South-Eastern fringe of Europe, Bulgaria still has a tendency to be overlooked and underestimated by the uninitiated. Not so by the international pharmaceuticals industry, however, which has long considered what is one of the EU’s most recent…

This report offers companies, investors, policymakers, and stakeholders crucial insight into the ecosystem of pharmaceutical companies in Ukraine, based on in-depth interviews conducted with leaders and pioneers across the value chain, from government representatives, the…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country  located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here